Need for perioperative blood transfusion is still high in certain types of oncological abdominal surgery. Allogeneic blood transfusion may be detrimental in cancer patients undergoing a potentially curative resection of malignant tumor, although the detailed mechanism of this effect is still under debate. We plan to evaluate whether a new, rotational thromboelastography-guided algorithm (ROTEM) to guide hemostatic resuscitation intra-operatively decreases the use of allogeneic blood products, the total amount of bleeding, transfusion related side effects, thromboembolic complications and costs. Its effect on each patient's post-operative hemostatic profile is also measured. 60 patients having a potentially curative pancreaticoduodenectomy (or resection of cauda of pancreas), total removal or partial resection of kidney and open radical cystectomy are recruited when an active blood loss of more than 1500 ml is estimated and/or measured and are randomized into two groups: one will be treated conventionally, ie. using massive transfusion protocol (MTP) if necessary, clinical judgement and conventional coagulation tests, the other treated using a ROTEM-based algorithm.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
ROTEM-guided protocol of hemostatic resuscitation
Clinical judgement and conventional coagulation tests
Tampere University Hospital
Tampere, Finland
Number of transfused red blood cell (RBC) units
Red blood cell units transfused per patient during operation or up to 24 hours after beginning of surgery
Time frame: 24 hours after beginning of surgery
Intensive care admissions
Number of patients admitted to intensive care or high dependency, if this is considered associating with the surgery
Time frame: 30 days after surgery
Length of hospital stay
Number of days patient is in hospital immediately after surgery
Time frame: 30 days after surgery
Transfusion-related side effects
Any side-effect considered or suspected originating from blood product transfusion
Time frame: 30 days after surgery
Thromboembolic events
Clinically diagnosed deep vein thrombosis, pulmonary embolism, stroke or other thromboembolic event
Time frame: 30 days after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.